Fulgent Genetics Q1 2024 Adj EPS $(0.01) May Not Be Comparable To $(0.32) Estimate, Sales $64.485M Miss $65.363M Estimate
Fulgent Genetics Q1 2024 Adj EPS $(0.01) May Not Be Comparable To $(0.32) Estimate, Sales $64.485M Miss $65.363M Estimate
Fulgent Genetics 2024年第一季度调整后每股收益美元（0.01）可能无法与预期的美元（0.32）相提并论，销售额为6,4485万美元未达到6,536.3万美元的预期
Fulgent Genetics (NASDAQ:FLGT) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.32) by 96.88 percent. This is a 95.45 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $64.485 million which missed the analyst consensus estimate of $65.363 million by 1.34 percent. This is a 2.54 percent decrease over sales of $66.168 million the same period last year.
Fulgent Genetics（纳斯达克股票代码：FLGT）公布的季度亏损为每股0.01美元，比分析师共识估计的美元（0.32美元）高出96.88％。这比去年同期每股亏损0.22美元（0.22美元）增长了95.45％。该公司公布的季度销售额为6,4485万美元，比分析师普遍预期的6536.3万美元低1.34％。这比去年同期的6616.8万美元的销售额下降了2.54％。